Maarssen, Netherlands

Alexander Benjamin Meijer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 11.0

ph-index = 1


Location History:

  • Amsterdam, NL (2018)
  • Maarssen, NL (2016 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alexander Benjamin Meijer: Innovator in Coagulation Factors

Introduction

Alexander Benjamin Meijer is a notable inventor based in Maarssen, Netherlands. He has made significant contributions to the field of coagulation factors, particularly through his innovative work on Factor VIII variants. With a total of 3 patents, Meijer's inventions are paving the way for advancements in medical treatments.

Latest Patents

Meijer's latest patents focus on modified coagulation factors. One of his key inventions is related to Factor VIII variants that have a decreased cellular uptake. This invention aims to improve the efficacy and safety of coagulation therapies. The modifications he has developed are crucial for enhancing the performance of Factor VIII molecules in clinical applications.

Career Highlights

Throughout his career, Alexander Benjamin Meijer has worked with prominent organizations in the medical field. Notably, he has been associated with the Sanquin Blood Supply Foundation and Novo Nordisk A/S. His work in these companies has allowed him to collaborate with leading experts and contribute to groundbreaking research in coagulation factors.

Collaborations

Meijer has collaborated with several professionals in his field, including Henriet Meems and Koenraad Mertens. These collaborations have enriched his research and have been instrumental in the development of his patented technologies.

Conclusion

Alexander Benjamin Meijer is a distinguished inventor whose work on coagulation factors has the potential to transform medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…